Literature DB >> 12586678

Indiscriminate investigations have adverse effects.

Julian H Barth, Richard G Jones.   

Abstract

Mesh：

Year:  2003        PMID： 12586678      PMCID： PMC1125247          DOI： 10.1136/bmj.326.7385.393

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Evidence base of clinical diagnosis: Rational, cost effective use of investigations in clinical practice.

Authors:  Ron Winkens; Geert-Jan Dinant
Journal:  BMJ       Date:  2002-03-30

2.  Lesson of the week: Hypothyroidism mimicking intra-abdominal malignancy.

Authors:  S T M Krishnan; Z Philipose; G Rayman
Journal:  BMJ       Date:  2002-10-26

Review 3.  Strategies to modify the test-requesting patterns of clinicians.

Authors:  C G Fraser; F P Woodford
Journal:  Ann Clin Biochem       Date:  1987-05       Impact factor: 2.057

4.  The impact of diagnostic testing on therapeutic interventions.

Authors:  D Verrilli; H G Welch
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

5.  Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.

Authors:  J Ferrer; M A Villarino; G Encabo; E Felip; B Bermejo; S Vilà; R Orriols
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860
  5 in total
  3 in total

1.  Methodology for constructing guidance.

Authors:  W S A Smellie; D I Finnigan; D Wilson; D Freedman; C A M McNulty; G Clark
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

2.  An evidence-base for laboratory endocrinology?

Authors:  Julian H Barth
Journal:  Clin Biochem Rev       Date:  2008-08

3.  Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink.

Authors:  Jessica Watson; Chris Salisbury; Penny Whiting; Jonathan Banks; Yvette Pyne; Willie Hamilton
Journal:  Br J Gen Pract       Date:  2019-06-17       Impact factor: 5.386
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.